For citations:
Sarvilina I.V., Galustyan A.N., Hadzhidis A.K., Sardaryan I.S., Lavrov N.V., Gromova O.A., Prokofieva Yu.S. Comparative clinical and economic analysis of using SYSADOA drugs containing chondroitin sulphate or influencing its biosynthesis in the treatment of patients with stage II knee osteoarthritis. FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology. 2019;12(4):255-266. (In Russ.) https://doi.org/10.17749/2070-4909.2019.12.4.255-266
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Email this article 